Periplasmic production via the pET expression system of soluble, bioactive human growth hormone

Protein Expression and Purification

Volumn 87, Issue 2, 2013, Pages 129-135

  Sockolosky, Jonathan T ^a   Szoka, Francis C ^a  

^a University of California   (United States)

Author keywords

Escherichia coli; Human growth hormone; Nb2; Periplasm; pET system

Indexed keywords

HUMAN GROWTH HORMONE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMISTRY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR CLONING; PLASMID; RAT; SURFACE PLASMON RESONANCE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN GROWTH HORMONE; HUMANS; PERIPLASM; PLASMIDS; RATS; SURFACE PLASMON RESONANCE;

MLCS; MLOWN;

EID: 84870659245     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2012.11.002     Document Type: Article

References (36)

1. Itakura, K., Hirose, T., Crea, R., Riggs, A.D., Heyneker, H.L., Bolivar, F., Boyer, H.W., Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science 198 (1977), 1056–1063.
2. Morrow, J.F., Cohen, S.N., Chang, A.C., Boyer, H.W., Goodman, H.M., Helling, R.B., Replication and transcription of eukaryotic DNA in Escherichia coli. Proc. Natl. Acad. Sci. USA 71 (1974), 1743–1747.
3. Cohen, S.N., Chang, A.C., Boyer, H.W., Helling, R.B., Construction of biologically functional bacterial plasmids in vitro. Proc. Natl. Acad. Sci. USA 70 (1973), 3240–3244.
4. Studier, F.W., Moffatt, B.A., Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189 (1986), 113–130.
5. Yoon, S.H., Kim, S.K., Kim, J.F., Secretary production of recombinant proteins in Escherichia coli. Recent Pat. Biotechnol. 4 (2010), 23–29.
6. Berkmen, M., Production of disulfide-bonded proteins in Escherichia coli. Protein Exp. Purif. 82 (2012), 240–251.
7. Corpas, E., Harman, S.M., Blackman, M.R., Human growth hormone and human aging. Endocr. Rev. 14 (1993), 20–39.
8. Cleland, J.L., Geething, N.C., Moore, J.A., Rogers, B.C., Spink, B.J., Wang, C.-W., Alters, S.E., Stemmer, W.P.C., Schellenberger, V., A novel long-acting human growth hormone fusion protein (VRS-317): enhanced in vivo potency and half-life. J. Pharm. Sci. 101 (2012), 2744–2754.
9. TM: A novel efficient nasal delivery system for human growth hormone based on Solutol HS15. J. Control. Release 162 (2012), 194–200.
10. de Schepper, J., Rasmussen, M.H., Gucev, Z., Eliakim, A., Battelino, T., Long-acting pegylated human GH in children with GH deficiency: a single-dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics. Eur. J. Endocrinol. 165 (2011), 401–409.
11. Péter, F., Bidlingmaier, M., Savoy, C., Ji, H.-J., Saenger, P.H., Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD). J. Clin. Endocr. Metab. 97 (2012), 400–407.
12. Amet, N., Wang, W., Shen, W.-C., Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats. J. Control. Release 141 (2010), 177–182.
13. Kirk, J., Indications for growth hormone therapy in children. Arch. Dis. Child. 97 (2012), 63–68.
14. Cuatrecasas, G., Alegre, C., Fernandez-Solà, J., Gonzalez, M.J., Garcia-Fructuoso, F., Poca-Dias, V., Nadal, A., Cuatrecasas, G., Navarro, F., Mera, A., Lage, M., Peinó, R., Casanueva, F., Liñan, C., Sesmilo, G., Coves, M.J., Izquierdo, J.P., Alvarez, I., Granados, E., Puig-Domingo, M., Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia. Pain 153 (2012), 1382–1389.
15. Sockolosky, J.T., Tiffany, M.R., Szoka, F.C., Engineering neonatal Fc receptor-mediated recycling and transcytosis in recombinant proteins by short terminal peptide extensions. Proc. Natl. Acad. Sci. USA 109 (2012), 16095–16100.
16. Patra, A.K., Mukhopadhyay, R., Mukhija, R., Krishnan, A., Garg, L.C., Panda, A.K., Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. Protein Exp. Purif. 18 (2000), 182–192.
17. Peterson, F.C., Anderson, P.J., Berliner, L.J., Brooks, C.L., Expression, folding, and characterization of small proteins with increasing disulfide complexity by a pT7-7-derived phagemid. Protein Exp. Purif. 15 (1999), 16–23.
18. Singh, S.M., Sharma, A., Panda, A.K., High throughput purification of recombinant human growth hormone using radial flow chromatography. Protein Exp. Purif. 68 (2009), 54–59.
19. Mukhija, R., Rupa, P., Pillai, D., Garg, L.C., High-level production and one-step purification of biologically active human growth hormone in Escherichia coli. Gene 165 (1995), 303–306.
20. Soares, C.R.J., Gomide, F.I.C., Ueda, E.K.M., Bartolini, P., Periplasmic expression of human growth hormone via plasmid vectors containing the lambdaPL promoter: use of HPLC for product quantification. Protein Eng. 16 (2003), 1131–1138.
21. Hsiung, H.M., Mayne, N.G., Becker, G.W., High–level expression, efficient secretion and folding of human growth hormone in Escherichia coli. Bio/Technology 4 (1986), 991–995.
22. Chang, C.N., Rey, M., Bochner, B., Heyneker, H., Gray, G., High-level secretion of human growth hormone by Escherichia coli. Gene 55 (1987), 189–196.
23. Gray, G.L., Baldridge, J.S., McKeown, K.S., Heyneker, H.L., Chang, C.N., Periplasmic production of correctly processed human growth hormone in Escherichia coli: natural and bacterial signal sequences are interchangeable. Gene 39 (1985), 247–254.
24. Ghorpade, A., Garg, L.C., Efficient processing and export of human growth hormone by heat labile enterotoxin chain B signal sequence. FEBS Lett. 330 (1993), 61–65.
25. Chang, J.Y., Pai, R.C., Bennett, W.F., Bochner, B.R., Periplasmic secretion of human growth hormone by Escherichia coli. Biochem. Soc. Trans. 17 (1989), 335–337.
26. Teresa, M., Ribela, C.P., Camargo, I.M., Oliveira, J.E., Bartolini, P., Single-step purification of recombinant human growth hormone (hGH) directly from bacterial osmotic shock fluids, for the purpose of (125)I-hGH preparation. Protein Expres. Purif. 18 (2000), 115–120.
27. Zhou, Y., Marks, J.D., Selection of phage antibody libraries for binding and internalization into mammalian cells. Kontermann, R., Dubel, S., (eds.) Antibody Engineering, 2010, Springer, New York, 183–195.
28. Koshland, D., Botstein, D., Secretion of beta-lactamase requires the carboxy end of the protein. Cell 20 (1980), 749–760.
29. Schellenberger, V., Wang, C., Geething, N.C., Spink, B.J., Campbell, A., To, W., Scholle, M.D., Yin, Y., Yao, Y., Bogin, O., Cleland, J.L., Silverman, J., Stemmer, W.P.C., A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner. Nat. Biotechnol. 27 (2009), 1186–1190.
30. Canova-Davis, E., Baldonado, I.P., Moore, J.A., Rudman, C.G., Bennett, W.F., Hancock, W.S., Properties of a cleaved two-chain form of recombinant human growth hormone. Int. J. Pept. Prot. Res. 35 (2009), 17–24.
31. Cunningham, B., Ultsch, M., De Vos, A., Mulkerrin, M., Clauser, K., Wells, J., Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254 (1991), 821–825.
32. de Vos, A., Ultsch, M., Kossiakoff, A., Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255 (1992), 306–312.
33. Langenheim, J.F., Chen, W.Y., Improving the pharmacokinetics/pharmacodynamics of prolactin, GH, and their antagonists by fusion to a synthetic albumin-binding peptide. J. Endocrinol. 203 (2009), 375–387.
34. Gout, P.W., Beer, C.T., Noble, R.L., Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res. 40 (1980), 2433–2436.
35. Tanaka, T., Shiu, R.P., Gout, P.W., Beer, C.T., Noble, R.L., Friesen, H.G., A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J. Clin. Endocr. Metab. 51 (1980), 1058–1063.
36. Fuh, G., Cunningham, B.C., Fukunaga, R., Nagata, S., Goeddel, D.V., Wells, J.A., Rational design of potent antagonists to the human growth hormone receptor. Science 256 (1992), 1677–1680.